Cryo-EM structure of Alzheimer's disease tau filaments with PET ligand MK-6240.
Kunach, P., Vaquer-Alicea, J., Smith, M.S., Monistrol, J., Hopewell, R., Moquin, L., Therriault, J., Tissot, C., Rahmouni, N., Massarweh, G., Soucy, J.P., Guiot, M.C., Shoichet, B.K., Rosa-Neto, P., Diamond, M.I., Shahmoradian, S.H.(2024) Nat Commun 15: 8497-8497
- PubMed: 39353896 
- DOI: https://doi.org/10.1038/s41467-024-52265-x
- Primary Citation of Related Structures:  
8UQ7 - PubMed Abstract: 
Positron Emission Tomography (PET) ligands have advanced Alzheimer's disease (AD) diagnosis and treatment. Using autoradiography and cryo-EM, we identify AD brain tissue with elevated tau burden, purify filaments, and determine the structure of second-generation high avidity PET ligand MK-6240 at 2.31 Å resolution, which bound at a 1:1 ratio within the cleft of tau paired-helical filament (PHF), engaging with glutamine 351, lysine 353, and isoleucine 360. This information elucidates the basis of MK-6240 PET in quantifying PHF deposits in AD and may facilitate the structure-based design of superior ligands against tau amyloids.
Organizational Affiliation: 
Department of Neurology, McGill University, Montreal, QC, Canada.